LGR5 and colorectal carcinoma: In summary, tissue-specific CDH17 works as a regulator of CRC SC biology by modulating LGR5 expression, Wnt signaling, MYC expression, and, therefore, stemness, and drug resistance capacities through SLC38A5 in metastatic cells (Fig. 8).